Dr. Zu-Chian Chiang | Biological macromolecules | Best Researcher Award |

Postdoctoral Fellow, at Fujian Normal University ,China

Dr. Zu-Chian Chiang (蔣祖搴), Ph.D., is a dedicated postdoctoral researcher currently working at the Biomedical Research Center of Southern China, Fujian Normal University, Qishan Campus, Fuzhou, China. With a strong academic and research foundation rooted in Taiwan, Dr. Chiang has developed expertise in biomedical sciences, materials chemistry, and clinical applications of advanced therapeutic technologies. He has worked with prestigious institutions such as Academia Sinica and National Taiwan University Hospital, contributing significantly to translational medicine, particularly in targeted cancer therapy and regenerative medicine. His collaborative and cross-disciplinary approach reflects a deep commitment to scientific advancement and public health.

Education 🎓

Dr. Chiang earned his Ph.D. in Materials and Chemical Engineering from the College of Engineering and Science at National United University, Taiwan (2008–2014), where he also served as a teaching assistant across various chemistry and engineering courses. He completed his M.S. in Chemistry at Tunghai University, Taiwan (2005–2007), laying the foundation for his specialization in organic chemistry and material science. His academic path has been enriched by mentorship from notable scholars such as Prof. An-Chong Chao and Prof. Feng-Di Lung.

Experience 👩‍

Dr. Chiang has over a decade of research experience across Taiwan and China. His postdoctoral journey began at the Clinical Trial Center of National Taiwan University Hospital, followed by appointments at Academia Sinica’s Institute of Biological Chemistry under the Taiwan Protein Project and Translational Innovation programs. Since 2019, he has been a postdoctoral fellow at Fujian Normal University, collaborating with Prof. Qi Chen. He also brings a strong teaching background, having served as a teaching and lab assistant in various chemistry and engineering courses during his graduate studies.

Research Interests 🔬

Dr. Chiang’s research centers on the development of functional peptides and biopolymeric complexes for cancer research and bone tissue engineering. He specializes in cutting-edge areas such as Antibody-Drug Conjugates (ADCs) for targeted cancer therapy, specific aptamers used as molecular agonists or antagonists, and the synthesis of multifunctional biomaterials for regenerative medicine. His interdisciplinary work bridges the gap between chemical engineering and biomedical applications, aiming to design smarter and more effective therapeutic strategies.

Awards 🏆

Dr. Chiang has been recognized for his excellence with several prestigious awards, including the 2020 Science and Technology Commissioner of Quanzhou (Fujian Province) and the 3rd Biotech Elite Training Reserve Program Award by the Executive Yuan, Taiwan. Other accolades include the Chung Hwa Rotary Doctoral Program Award (2012), the Outstanding Doctoral Scholarship at National United University (2010), and the Master’s Program Scholarship from the Hunan Fellow Association (2007). His leadership is also recognized by Rotary International through various honors and leadership roles.

Top Noted Publications 📚

Dr. Chiang has authored and co-authored several impactful publications in international journals. His recent works include:

Development of 7DC-DM1, a CD47-targeting ADC with anti-tumor effects (IJ Biological Macromolecules, 2025).

Immuno-enhancement in lung cancer therapy via thalidomide and anti-PD-1 antibodies (Current Pharmaceutical Biotechnology, 2024).

CD47-specific ADCs for NSCLC treatment, demonstrating strong preclinical efficacy (Frontiers in Oncology, 2022).

Conclusion

Dr. Zu-Chian Chiang is a highly accomplished and promising researcher in the biomedical sciences, with a proven track record of impactful research, academic excellence, and leadership. His interdisciplinary expertise, from molecular synthesis to clinical trial collaboration, positions him as an outstanding candidate for any Best Researcher Award. With his continued contributions to science and society, Dr. Chiang exemplifies the qualities of innovation, dedication, and global impact.

Prof Alireza Partoazar | Medical Nanotechnology | Best Researcher Award |

Supervision, at Tehran University of Medical Sciences ,Iran

Dr. Alireza Partoazar is an accomplished Associate Professor at the Experimental Medicine Research Center, Tehran University of Medical Sciences (TUMS), Iran. With a solid foundation in medical nanotechnology and over two decades of academic and research experience, he has contributed significantly to the fields of drug delivery, pharmacology, and preclinical studies. Dr. Partoazar combines innovation with a commitment to education and ethics, mentoring graduate students and leading research initiatives that bridge science and application. His collaborations with international pharmaceutical companies and active involvement in research ethics demonstrate a balanced profile of scientific leadership and social responsibility.

Professional Profile

Google Scholar

Education 🎓

Dr. Partoazar earned his Ph.D. in Medical Nanotechnology from the School of Advanced Technologies in Medicine at TUMS in 2013, where he graduated with honors. Prior to this, he completed an M.Sc. in Medical Microbiology from Tabriz University of Medical Sciences in 2001. His academic journey began with a B.Sc. in Medical Laboratory Diagnosis from Zahedan Azad University of Medical Sciences in 1992. His multidisciplinary academic background laid the groundwork for a rich career in experimental and translational medicine.

Experience 👩‍

With over 25 years of experience, Dr. Partoazar has served in various academic roles at TUMS, including Lab Assistant, Lab Director, Assistant Professor, and currently, Associate Professor. His long-term affiliation with the Department of Pharmacology has included both teaching and research duties, especially in practical pharmacology and animal modeling. He has been actively involved as a member and referee in the ethics committee for animal research, and leads workshops on animal ethics and research techniques, demonstrating a strong commitment to responsible research practices.

Research Interests 🔬

His research focuses on drug delivery systems, nanotechnology, experimental pharmacology, and preclinical models of disease, including studies on neuropathy, inflammation, wound healing, osteoporosis, and immune responses. Dr. Partoazar has played a leading role in advancing nano-based drug formulations such as liposomes and nanocochleates, particularly for immunosuppressive therapies. His expertise in both in vitro and in vivo pharmacological evaluations positions him as a key contributor to translational medicine research.

Awards 🏆

Dr. Partoazar has received multiple accolades throughout his academic and professional career. He was recognized as a Top Graduate by the School of Advanced Technologies in Medicine at TUMS. He has been awarded several TUMS Research Grants and Workshop Awards, reflecting both his scientific excellence and educational leadership. Since 2015, he has served as the Chief Scientific Advisor for Pharmin USA, LLC, a testament to the global relevance of his research contributions.

Top Noted Publications 📚

1. Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects
Authors: N. Kianvash, A. Bahador, M. Pourhajibagher, H. Ghafari, V. Nikoui, A.R. Partoazar, et al.
Journal: Drug Delivery and Translational Research
Citations: 132
Year: 2017

2. Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system
Authors: F. Esmaeili, S. Rajabnejhad, A.R. Partoazar, S.E. Mehr, R. Faridi-Majidi, et al.
Journal: Pharmaceutical Development and Technology
Citations: 94
Year: 2016

3. Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer’s disease model
Authors: P.M. Saffari, S. Alijanpour, N. Takzaree, M. Sahebgharani, A.R. Partoazar, et al.
Journal: Life Sciences
Citations: 92
Year: 2020

4. Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
Authors: A. Partoazar, S. Nasoohi, S.M. Rezayat, K. Gilani, S.E. Mehr, A. Amani, et al.
Journal: Fundamental & Clinical Pharmacology
Citations: 70
Year: 2017

5. Comparison of liquid-liquid extraction-thin layer chromatography with solid-phase extraction-high-performance thin layer chromatography in detection of urinary morphine
Authors: A. Ahadi, A. Partoazar, M.H. Abedi-Khorasgani, S.V. Shetab-Boushehri
Journal: Journal of Biomedical Research
Citations: 47
Year: 2011